Skip to main content
SpringerLink
Log in

Amphotericin B in the Treatment of Coccidioidomycosis

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

In the 25 years since its introduction, amphotericin B has demonstrated clear value in the management of coccidioidomycosis. However, its effectiveness is less certain than in diseases due to other fungal aetiological agents, even when the loci of infection and in vitro drug susceptibilities are identical. The refractoriness of coccidioidomycosis may relate to the unique ability of each Coccidioides immitis spherule to release hundreds of endospors, thus maximally challenging host defence mechanisms. Amphotericin B is most likely to be effective where there is evidence of intact cell-mediated immunity against C. immitis (i.e. positive coccidioidin or spherulin skin test; low titre of complement fixing antibody), and structural damage to tissues. When bones and joints are involved, as is frequently the case, adjunctive surgical management is generally required. Patients with structural lung disease (i.e. cysts and/or cavities) show variable, often minimal, response to treatment.

Amphotericin B has transformed coccidioidal meningitis from a routinely fatal disease to one where prolonged survival is possible. However, the drug must be given by the intrathecal route, and for periods of years, before the possibility of cure can be considered. Relapses of bone, joint and meningeal coccidioidomycosis are common and should be anticipated, especially in patients with impaired immunity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arfania, D.; Everett, E.D.; Nolph, K.D. and Rubin, J.: Uncommon causes of peritonitis in patients undergoing peritoneal dialysis. Archives of Internal Medicine 141: 61–64 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Atkinson, A.J.Jr and Bennett, J.E.: Amphotericin B pharmacokinetics in humans. Antimicrobial Agents and Chemotherapy 13: 271–276 (1978).

    Article  PubMed  Google Scholar 

  • Atkinson, A.J.Jr and Bindschadler, D.D.: Pharmacokinetics of intrathecally administered amphotericin B. American Review of Respiratory Disease 99: 917–924 (1969).

    PubMed  CAS  Google Scholar 

  • Barbour, G.L.; Straub, K.D.; O’Neal, B.L. and Leatherman, J.W.: Vasopressin-resistant nephrogenic diabetes insipitus. A result of amphotericin B therapy. Archives of Internal Medicine 139: 86–88 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Baum, G.L. and Schwarz, J.: Coccidioidomycosis: A review. American Journal of the Medical Sciences 230: 82–97 (1955).

    Article  PubMed  CAS  Google Scholar 

  • Bayer, A.S. and Guze, L.B.: Fungal arthritis. II. Coccidioidal synovitis: Clinical, diagnostic, therapeutic, and prognostic considerations. Seminars in Arthritis and Rheumatism 8: 200–211 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Bennett, J.E.: Chemotherapy of systemic mycoses. New England Journal of Medicine 290: 30–32 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Boddicker, J.H.; Fong, D.; Walsh, T.E.; Schillaci, R.F.; Moniot, A.L. and Catanzaro, A.: Bone and gallium scanning in the evaluation of disseminated coccidioidomycosis. American Review of Respiratory Disease 122: 279–287 (1980).

    PubMed  CAS  Google Scholar 

  • Buchsbaum, H.W.: Clinical management of coccidioidal meningitis; in Ajello (Ed.) Coccidioidomycosis. Current Clinical and Diagnostic Status, pp. 191–199 (Symposia Specialists, Miami 1977).

    Google Scholar 

  • Bullock, W.E.; Luke, R.G.; Nuttall, CW. and Bhathena, D.: Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys. Antimicrobial Agents and Chemotherapy 10: 555–563 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Butler, W.T.; Bennett, J.E.; Alling, D.W.; Wetlake, P.T.; Utz, J.P. and Hill, G.J.II: Nephrotoxicity of amphotericin B. Early and late effects in 81 patients. Annals of Internal Medicine 61: 175–187 (1964).

    PubMed  CAS  Google Scholar 

  • Carnevale, N.T.; Galgiani, J.N.; Stevens, D.A.; Herrick, M.A. and Langston, J.W.: Amphotericin B-induced myelopathy. Archives of Internal Medicine 140: 1189–1192 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Collins, M.S.; Pappagianis, D.: Uniform susceptibility of various strains of Coccidioides immitis to amphotericin B. Antimicrobial Agents and Chemotherapy 11: 1049–1055 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Drutz, D.J.: Newer antifungal agents and their use, including an update on amphotericin B and flucytosine; in Remington and Swartz (Eds) Current Topics in Infectious Diseases, Vol. 3, pp. 97–135 (McGraw-Hill Book Co., New York 1982).

    Google Scholar 

  • Drutz, D.J. and Catanzaro, A.: Coccidioidomycosis: Part 1. American Review of Respiratory Disease 117: 559–585 (1978a).

    PubMed  CAS  Google Scholar 

  • Drutz, D.J. and Catanzaro, A.: Coccidioidomycosis: Part 2. American Review of Respiratory Disease 117: 727–771 (1978b).

    PubMed  CAS  Google Scholar 

  • Drutz, D.J. and Huppert, M.: Coccidioidomycosis: Factors affecting the host-parasite interaction. Journal of Infectious Diseases 147: 372–390 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Drutz, D.J.; Spickard, A.; Rogers, D.E. and Koenig, M.G.: Treatment of disseminated mycotic infections. A new approach to amphotericin B therapy. American Journal of Medicine 45: 405–418 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Einstein, H.E.: Some aspects of coccidioidomycosis therapy; in Ajello (Ed.) Coccidioidomycosis, pp. 123–125 (University of Arizona Press, Tucson 1967).

    Google Scholar 

  • Einstein, H.E.; Holeman, C.W. Jr.; Sandidge, L.L. and Holden, D.H.: Coccidioidal meningitis. The use of amphotericin B in treatment. California Medicine 94: 339–343 (1961).

    PubMed  CAS  Google Scholar 

  • Feely, J.; Heidemann, H.; Gerkens, J.; Roberts, L.J.II and Branch, R.A.: Sodium depletion enhances nephrotoxicity of amphotericin B. Lancet 1: 1422–1423 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Fiese, M.J.: Coccidioidomycosis (Charies C Thomas, Springfield 1958).

    Google Scholar 

  • Gerkens, J.F. and Branch, R.A.: The influence of sodium status and furosemide on canine acute amphotericin B nephrotoxicity. Journal of Pharmacology and Experimental Therapeutics 214: 306–311 (1980).

    PubMed  CAS  Google Scholar 

  • Goldstein, E.J.; Winship, M.J. and Pappagianis, D.: Ventricular fluid and the management of coccidoidial meningitis. Annals of Internal Medicine 77: 243–246 (1972).

    PubMed  CAS  Google Scholar 

  • Gouge, T.H. and Andriole, V.T.: An experimental model of amphotericin B nephrotoxicity with renal tubular acidosis. Journal of Laboratory and Clinical Medicine 78: 713–724 (1971).

    PubMed  CAS  Google Scholar 

  • Graybill, J.R. and Craven, P.C.: Antifungal agents used in systemic mycoses. Activity and therapeutic use. Drugs 25: 41–62 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Hardenbrook, M.H. and Barriere, S.L.: Coccidioidomycosis: Evaluation of parameters used to predict outcome with amphotericin B therapy. Mycopathologia 78: 65–71 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Hyde, L.: Coccidioidal pulmonary cavitation. Diseases of the Chest 54(Suppl. 1): 17–21 (1968).

    Google Scholar 

  • Keane, J.R.: Cisternal puncture complications. Treatment of coccidioidal meningitis with amphotericin B. California Medicine 119: 10–15 (1973).

    PubMed  CAS  Google Scholar 

  • Kelly, P.C.: Coccidioidal meningitis; in Stevens (Ed.) Coccidioidomycosis: A Text, pp. 163–193 (Plenum Press, New York 1980).

    Google Scholar 

  • Littman, M.L.; Horowitz, P.L. and Swadey, J.G.: Coccidioidomycosis and its treatment with amphotericin B. American Journal of Medicine 24: 568–592 (1958).

    Article  PubMed  CAS  Google Scholar 

  • Medoff, G.; Dismukes, W.E.; Meade, R.H.III and Moses, J.M.: A new therapeutic approach to Candida infections. Archives of Internal Medicine 130: 241–245 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Miller, R.P. and Bates, J.H.: Amphotericin B toxicity. A followup report of 53 patients. Annals of Internal Medicine 71: 1089–1095 (1969).

    PubMed  CAS  Google Scholar 

  • Reynolds, E.S.; Tomkiewicz, Z.M. and Dammin, G.J.: The renal lesion related to amphotericin B treatment for coccidioidomycosis. Medical Clinics of North America 47: 1149–1154 (1963).

    PubMed  CAS  Google Scholar 

  • Rowland, V.S.; Westfall, R.E.; Hinchcliffe, W.A. and Jarrett, P.B.: Acute respiratory failure in miliary coccidioidomycosis; in Ajello (Ed.) Coccidioidomycosis. Current Clinical and Diagnostic Status, pp. 139–155 (Symposia Specialists, Miami 1977).

    Google Scholar 

  • Sarosi, G.A.; Parker, J.D.; Doto, I.L. and Tosh, F.E.: Chronic pulmonary coccidioidomycosis. A National Communicable Disease Center Cooperative Mycoses Study. New England Journal of Medicine 283: 325–329 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Utz, J.P.; Bennett, J.E.; Brandriss, M.W.; Butler, W.T. and Hill, G.J.II: Amphotericin B toxicity. Combined clinical staff conference at the National Institutes of Health. Annals of Internal Medicine 61: 334–354 (1964).

    CAS  Google Scholar 

  • Winn, R.E.; Bower, J.H. and Richards, J.F.: Acute toxic delerium. Nephrotoxicity of intrathecal administration of amphotericin B. Archives of Internal Medicine 139: 706–707 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Winn, W.A.: The use of amphotericin B in the treatment of coccidioidal disease. American Journal of Medicine 27: 617–635 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Winn, W.A.: The treatment of coccidioidal meningitis. California Medicine 101: 78–89 (1964).

    PubMed  CAS  Google Scholar 

  • Wright, D.G.; Robichaud, K.J.; Pizzo, P.A. and Deisseroth, A.B.: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. New England Journal of Medicine 304: 1185–1189 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases Section, Audie Murphy Memorial Veterans’ Hospital, and the Departments of Medicine and Microbiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas, 78284, USA

    David J. Drutz

Authors
  1. David J. Drutz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drutz, D.J. Amphotericin B in the Treatment of Coccidioidomycosis. Drugs 26, 337–346 (1983). https://doi.org/10.2165/00003495-198326040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198326040-00003

Keywords

Search

Navigation